Tech Company Financing Transactions
SynapDx Funding Round
SynapDx secured a $6 million Series A funding round on 12/11/2012. Backers included General Catalyst Partners and North Bridge Venture Partners.
Transaction Overview
Company Name
Announced On
12/11/2012
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series A
Investors
General Catalyst Partners (Hemant Taneja)
North Bridge Venture Partners (William Geary)
Proceeds Purpose
The company will use the funding to support further development of its breakthrough blood-based ASD diagnostic test, designed to identify children with ASD by age 36 months.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stanley Lapidus
Chief Financial Officer
Bill Romeo
Browse more venture capital transactions:
Prev: 12/11/2012: Reval venture capital transaction
Next: 12/11/2012: RobotsApps.com venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs